BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22230198)

  • 21. In vitro structure-function studies of the Bacillus subtilis tyrS mRNA antiterminator: evidence for factor-independent tRNA acceptor stem binding specificity.
    Gerdeman MS; Henkin TM; Hines JV
    Nucleic Acids Res; 2002 Feb; 30(4):1065-72. PubMed ID: 11842119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterizing riboswitch function: identification of Mg2+ binding site in T box antiterminator RNA.
    Jack KD; Means JA; Hines JV
    Biochem Biophys Res Commun; 2008 May; 370(2):306-10. PubMed ID: 18371302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The T-Box Riboswitch: tRNA as an Effector to Modulate Gene Regulation.
    Kreuzer KD; Henkin TM
    Microbiol Spectr; 2018 Jul; 6(4):. PubMed ID: 30051797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T box riboswitches in Actinobacteria: translational regulation via novel tRNA interactions.
    Sherwood AV; Grundy FJ; Henkin TM
    Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1113-8. PubMed ID: 25583497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors that influence T box riboswitch efficacy and tRNA affinity.
    Zeng C; Zhou S; Bergmeier SC; Hines JV
    Bioorg Med Chem; 2015 Sep; 23(17):5702-8. PubMed ID: 26220520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4,5-Disubstituted oxazolidinones: High affinity molecular effectors of RNA function.
    Anupam R; Nayek A; Green NJ; Grundy FJ; Henkin TM; Means JA; Bergmeier SC; Hines JV
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3541-4. PubMed ID: 18502126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and stereospecificity of 4,5-disubstituted oxazolidinone ligands binding to T-box riboswitch RNA.
    Orac CM; Zhou S; Means JA; Boehm D; Bergmeier SC; Hines JV
    J Med Chem; 2011 Oct; 54(19):6786-95. PubMed ID: 21812425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New tRNA contacts facilitate ligand binding in a
    Sherwood AV; Frandsen JK; Grundy FJ; Henkin TM
    Proc Natl Acad Sci U S A; 2018 Apr; 115(15):3894-3899. PubMed ID: 29581302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The dynamic nature of RNA as key to understanding riboswitch mechanisms.
    Haller A; Soulière MF; Micura R
    Acc Chem Res; 2011 Dec; 44(12):1339-48. PubMed ID: 21678902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of transfer RNA tertiary structure on aminoacylation efficiency by glutaminyl and cysteinyl-tRNA synthetases.
    Sherlin LD; Bullock TL; Newberry KJ; Lipman RS; Hou YM; Beijer B; Sproat BS; Perona JJ
    J Mol Biol; 2000 Jun; 299(2):431-46. PubMed ID: 10860750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluorescence assays for monitoring RNA-ligand interactions and riboswitch-targeted drug discovery screening.
    Liu J; Zeng C; Zhou S; Means JA; Hines JV
    Methods Enzymol; 2015; 550():363-83. PubMed ID: 25605395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct evaluation of tRNA aminoacylation status by the T-box riboswitch using tRNA-mRNA stacking and steric readout.
    Zhang J; Ferré-D'Amaré AR
    Mol Cell; 2014 Jul; 55(1):148-55. PubMed ID: 24954903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-crystal structure of a T-box riboswitch stem I domain in complex with its cognate tRNA.
    Zhang J; Ferré-D'Amaré AR
    Nature; 2013 Aug; 500(7462):363-6. PubMed ID: 23892783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Library of 1,4-disubstituted 1,2,3-triazole analogs of oxazolidinone RNA-binding agents.
    Acquaah-Harrison G; Zhou S; Hines JV; Bergmeier SC
    J Comb Chem; 2010 Jul; 12(4):491-6. PubMed ID: 20557032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The T box and S box transcription termination control systems.
    Grundy FJ; Henkin TM
    Front Biosci; 2003 Jan; 8():d20-31. PubMed ID: 12456320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific interaction of the RNA-binding domain of the bacillus subtilis transcriptional antiterminator GlcT with its RNA target, RAT.
    Langbein I; Bachem S; Stülke J
    J Mol Biol; 1999 Nov; 293(4):795-805. PubMed ID: 10543968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring uncharged tRNA during transcription of the Bacillus subtilis glyQS gene.
    Grundy FJ; Yousef MR; Henkin TM
    J Mol Biol; 2005 Feb; 346(1):73-81. PubMed ID: 15663928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequence, structure, and stacking: specifics of tRNA anchoring to the T box riboswitch.
    Grigg JC; Ke A
    RNA Biol; 2013 Dec; 10(12):1761-4. PubMed ID: 24356646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. (Dis)similar Analogues of Riboswitch Metabolites as Antibacterial Lead Compounds.
    Matzner D; Mayer G
    J Med Chem; 2015 Apr; 58(8):3275-86. PubMed ID: 25603286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of induced fit in the interaction of Bacillus subtilis trp RNA-binding attenuator protein and its RNA antiterminator target oligomer.
    Flynn PF; Wendt A; Gollnick P
    Proteins; 2002 Dec; 49(4):432-8. PubMed ID: 12402353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.